Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/bmj.f7367 | DOI Listing |
Int J Antimicrob Agents
November 2024
Venus Medicine Research Centre, India. Electronic address:
This study assessed the nephrotoxicity and toxicokinetic profile of VRP-034 (novel formulation of polymyxin B [PMB]) compared to marketed PMB over a seven-day repeat-dose regimen. Three objectives were pursued: evaluating PMB pharmacokinetics in both groups, alongside assessing VRP-034's impact on mitigating PMB-associated kidney injury; analyzing kidney injury reversibility; and validating novel kidney injury biomarkers against traditional markers using histopathology scoring. 68 Sprague-Dawley rats were divided into three groups: 30 each for marketed PMB and VRP-034 groups, and 8 for control.
View Article and Find Full Text PDFParasitol Res
October 2024
Department of Veterinary Microbiology, College of Veterinary Sciences, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, Haryana, India.
Sci Rep
September 2024
Department of Urology, University of Alabama Birmingham, Birmingham, AL, USA.
Calcium oxalate (CaOx) kidney stones may be associated with urinary tract infections (UTIs). However, the mechanisms for this association are not well-established. The objective of this study was to investigate the effect of oxalate on immunity and UTI development in vivo.
View Article and Find Full Text PDFDev Biol
January 2025
The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, 04609, USA. Electronic address:
Immature oocytes enclosed in primordial follicles stored in female ovaries are under constant threat of DNA damage induced by endogenous and exogenous factors. Checkpoint kinase 2 (CHEK2) is a key mediator of the DNA damage response (DDR) in all cells. Genetic studies have shown that CHEK2 and its downstream targets, p53, and TAp63, regulate primordial follicle elimination in response to DNA damage.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!